Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1Gynecologic 1

Conditions

Head and Neck Neoplasms 3Unspecified Adult Solid Tumor, Protocol Specific 2Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Precancerous Conditions 1Ovarian Neoplasms 1Oligodendroglioma 1Neuroblastoma 1Neoplasms 1Mouth Neoplasms 1Kidney Neoplasms 1Glioma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Ovarian Epithelial 1Breast Neoplasms 1Brain Neoplasms 1Astrocytoma 1

Interventions

Colposcopy 13Imiquimod 12Conization 11Papillomavirus Vaccines 8Cryotherapy 6Vaccines 5Papanicolaou Test 4Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 4Acetic Acid 4Watchful Waiting 3Vaginal Smears 3Surveys and Questionnaires 3Biopsy 3human papillomavirus vaccine, L1 type 16, 18 2Spectrometry, Fluorescence 2Proflavine 2Mass Screening 2Immunohistochemistry 2Human Papillomavirus DNA Tests 2High-Throughput Screening Assays 2Flow Cytometry 2Curcumin 2Blood Specimen Collection 2pembrolizumab 1nimotuzumab 1lime 1human papillomavirus vaccine, TA 1hecolin 1efineptakin alfa 1Zoledronic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Uterine Cervical Dysplasia × Fenretinide × Clear all
NCT00003075 2018-10-24

Fenretinide in Treating Patients With Cervical Neoplasia

M.D. Anderson Cancer Center

Phase 3 Completed
39 enrolled
GynecologicOther neoplasm

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡